Fennec Pharmaceuticals to report first-quarter 2026 results, hosts conference call and webcast

Fennec Pharmaceuticals Inc.

FENC

0.00

Fennec Pharmaceuticals scheduled release of first-quarter 2026 financial results before U.S. market open May 14, 2026.
Management set conference call, webcast for 8:30 a.m. ET May 14, 2026 to discuss results; webcast available at https://edge.media-server.com/mmc/p/2iptdco4.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fennec Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605070636PRIMZONEFULLFEED9714840) on May 07, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.